Peroxisome proliferators are a group of non-genotoxic hepatic carcinogens that have been proposed to act by increasing oxidative damage in the liver. To test this hypothesis, we have examined if hepatic catalase overexpression in peroxisome proliferator-treated mice influences the induction of cell proliferation or the activation of transcription factors involved in cell proliferation. Transgenic mice or non-transgenic littermates were fed either 0.01% ciprofibrate or a control diet for 21 days. Fatty acyl CoA oxidase activity was not significantly affected by catalase overexpression, although the ratio of fatty acyl CoA oxidase to catalase was significantly decreased in transgenic animals. The labeling index in hepatocytes was significantly increased by ciprofibrate in non-transgenic mice, but catalase overexpression significantly inhibited this increase. Ciprofibrate increased the activation of nuclear factor (NF)-κB in non-transgenic mice, but this increase was inhibited by catalase overexpression. Ciprofibrate also increased AP-1 activation, but catalase overexpression did not significantly inhibit this increase, although AP-1 activation was 40% lower in transgenic mice. These results support the hypothesis that active oxygen plays a role in the induction of cell proliferation by the peroxisome proliferator ciprofibrate and therefore may be important in the carcinogenicity of these agents.
Introduction
Peroxisome proliferators are a group of chemically distinct compounds that are capable of eliciting a persistent peroxisome proliferation in hepatocytes and of promoting liver tumors in rodents (1) (2) (3) . These chemicals significantly increase the size and number of peroxisomes as well as several enzymes of the peroxisomal β-oxidation pathway (4-7). The rate limiting enzyme of this pathway, fatty acyl CoA oxidase (FAO*), produces hydrogen peroxide (H 2 O 2 ) as a by-product. The activity of this enzyme is increased 10-to 15-fold by peroxisome proliferators such as ciprofibrate (1) . In contrast, the activity of the H 2 O 2 -detoxifying enzyme catalase is only increased~2-fold by peroxisome proliferators (1) . It has been proposed that this imbalance in FAO and catalase induction *Abbreviations: NF, nuclear factor; FAO, fatty acyl CoA oxidase; BrdU, bromodeoxyuridine; EMSA, electrophoretic mobility shift assays. may result in the accumulation of H 2 O 2 , which could at least partially be responsible for the effects of peroxisome proliferators.
In addition to these biochemical changes, peroxisome proliferators increase cell proliferation in the liver soon after they are administered (4) . Cell proliferation eventually returns to basal levels for most peroxisome proliferators; one exception is Wy-14 643, which induces long-term cell proliferation (8) (9) (10) (11) . In addition to stimulating DNA synthesis, peroxisome proliferators have been shown to inhibit apoptosis in normal and preneoplastic hepatocytes (12) (13) (14) (15) . The withdrawal of peroxisome proliferators leads to rapid reduction in liver wt, presumably by apoptosis (12) .
In spite of the data described above, the link between peroxisome proliferators and hepatocarcinogenesis on a molecular and cellular level is not fully understood. Recently, we have shown that the peroxisome proliferator ciprofibrate increases the DNA-binding activity of nuclear factor-κB (NF-κB) in rats (16) . NF-κB is normally found in the cytoplasm as an inactive complex consisting of two subunits (p50 and p65), which are bound to an inhibitory subunit, IκB (17) . Upon activation, NF-κB is released from IκB and translocates to the nucleus, where it increases the transcription of specific genes (18) . NF-κB can be activated in many different cell types by a variety of stimuli (19) . Reactive oxygen species, including H 2 O 2 , are potent activators of NF-κB (20) , while the addition of antioxidants such as vitamin E or overexpression of antioxidant enzymes such as glutathione peroxidase can block activation of NF-κB (21, 22) . This has led us to speculate that peroxisome proliferators activate NF-κB through the induction of H 2 O 2 -generating enzymes such as FAO.
Several studies have indicated that NF-κB is an important transcriptional regulator in the liver. NF-κB is activated after partial hepatectomy and during the 'acute-phase' response (23) . NF-κB induction after partial hepatectomy is rapid and transient, with maximal stimulation occurring within 30 min and a return to basal levels within 2 h (23). In addition, disruption of the NF-κB p65 subunit gene κB in mice leads to embryonic lethality by massive degeneration of the liver due to apoptosis (24) .
The transcription factor AP-1, a heterodimer of c-fos and c-jun, is also known to play a central role in cell proliferation and differentiation (25, 26) . Additionally, AP-1 activity can be regulated by the redox status of a cell (20, 27, 28) , suggesting that AP-1 activity could be modulated by H 2 O 2 levels.
To study the role of H 2 O 2 in the cellular response to peroxisome proliferators, we have developed transgenic mice that overexpress catalase specifically in the liver (29) . Three lines of these mice show 3-to 4-fold higher hepatic catalase activities than non-transgenic litter-mates. We have investigated the response to the peroxisome proliferator ciprofibrate in these transgenic mice. Our results show that catalase overexpression inhibits ciprofibrate-induced DNA synthesis. These studies also show that ciprofibrate can activate NF-κB in the livers of mice, and that this activation was inhibited by catalase overexpression. AP-1 activity was also activated by this peroxisome proliferator; catalase overexpression led to a modest reduction in AP-1 induction. Overall, these results indicate that H 2 O 2 can have a significant influence on proliferation and transcription factor activation in the cellular response to peroxisome proliferators.
Materials and methods

Chemicals
Ciprofibrate was a generous gift from Sanofi Research (Malvern, PA).
Animals and treatment
Transgenic mice overexpressing catalase were produced as previously described (29) . Three of the founder lines (V.5, V.6 and V.39) exhibited a 3-632 to 4-fold increase in catalase activity over non-transgenic littermates. In a 2ϫ2 factorial study, 10 7-to 8-week-old transgenic and 10 non-transgenic female mice of the line V.5 were fed either control diets or diets containing 0.01% ciprofibrate for a period of 21 days. Two days before the mice were killed, each mouse was surgically implanted s.c. with an Alzet osmotic minipump (ALZA Scientific Products, Palo Alto, CA), which contained a total volume of 100 µl of 20 mg/ml bromodeoxyuridine (BrdU) (Sigma Chemical Co., St Louis, MO), at a pumping rate of 1 µl/h. At the end of the treatment, animals were killed by overexposure to carbon dioxide. Livers were immediately removed and weighed. Two small slices from different lobes of the liver were randomly cut and placed in a tissue cassette (Miles Laboratories, Inc., Elkhart, IN). Tissue cassettes were labeled and placed in 10% buffered neutral formalin. The remainder of each liver was quickly frozen in liquid nitrogen.
Biochemical determinations
Liver homogenates were used for the measurement of both FAO and catalase activities. The activity of FAO was measured by the fluorimetric method of Poosch and Yamazaki (30) . Catalase activity was analyzed by the method of Beers and Sizer (31) .
Quantitation of DNA synthesis
The liver samples held in tissue cassettes were kept in 10% buffered formalin for 24 h. The tissues were then transferred to 70% ethanol for 3 days. The tissues were paraffin-embedded and sectioned at 5 µm (sectioning was performed by the histology laboratory, Department of Pathology, University of Kentucky). The rate of replicative DNA synthesis was determined using the BrdU immunohistochemical staining protocol described by Goldsworthy et al. (32) . Anti-BrdU antibody (1 ml of 1:25 dilution) (Becton Dickinson Immunocytometry Systems, San Jose, CA) was used to detect replicating cells. Cells that had incorporated BrdU were easily identified by black pigment over their nuclei. At least 3000 nuclei were counted for each slide, and the labeling index was determined.
Preparation of nuclear extracts and electrophoretic mobility shift assays (EMSA)
Nuclear extracts were prepared from frozen liver tissue following the method of Deryckere and Gannon (33) . The protein concentrations in the nuclear extracts were measured by the Bio-Rad protein detection kit (Bio-Rad Laboratories, Hercules, CA). The DNA binding activities of the transcription factors NF-κB, AP-1 and SP-1 were determined using EMSA essentially as described (16) . Oligonucleotides containing consensus binding sites for NF-κB, AP-1 and SP-1 were obtained from Promega Corporation (Madison, WI). Liver tissue nuclear extracts (10 µg/ 25 µl) were pre-incubated with 5 µl of 5ϫ incubation buffer [50 mM Tris, 500 mM NaCl, 5 mM DTT, 5 mM EDTA, 20% glycerol (v/v) and 0.4 mg/ml salmon sperm DNA] on ice. For competition assays, a 25-or 50-fold molar excess of unlabeled oligonucleotide was also added. For antibody supershift assays, 1 µl of both rabbit anti-fos and rabbit anti-jun antiserum (for AP-1) or 1 µl of rabbit anti-p50 or rabbit anti-p65 antiserum (for NF-κB) was also added. Antisera were purchased from Santa Cruz Biotech., Inc. (Santa Cruz, CA). After a 15-min incubation on ice, 50 000 c.p.m. of the respective labeled oligonucleotide were added and the tubes were incubated for 20 min at room temperature. Samples were run on a 6% non-denaturing polyacrylamide gel in 0.5ϫTris-Borate-EDTA buffer at 150 V for 2 h. Following completion of the run, the gel was transferred to a blotter paper and dried under vacuum for 30 min. The dried gel was then exposed to X-ray film at -80°C and developed. A densitometric imaging system (Ambis, San Diego, CA) was used to quantify the amount of radioactivity in a particular band.
Statistical analysis
The data were analyzed by two-way analysis of variance. If significant interactions were seen the data were further analyzed by Tukey's test.
Results
Peroxisome proliferators have multiple effects in the liver when administered to rodents: stimulation of cell proliferation, proliferation of peroxisomes and induction of the enzymes of the peroxisomal β-oxidation pathway. This increased enzyme activity may increase cellular H 2 O 2 levels, leading to cellular 633 oxidative stress, which may be ultimately involved in the carcinogenic properties of these compounds. The exact role of H 2 O 2 , with regards to biochemical changes in the liver, is not fully understood. To address this issue, we have generated transgenic mice that overexpress catalase specifically in the liver (29) . Since catalase is the major H 2 O 2 detoxifying enzyme in the liver, we reasoned that H 2 O 2 levels would be reduced in these mice under normal conditions and in the presence of peroxisome proliferators. We used a 2ϫ2 factorial study; transgenic or non-transgenic mice were fed either a control diet or a diet containing 0.01% ciprofibrate for a period of 3 weeks.
We have previously described three lines of transgenic mice that exhibited 3-to 4-fold higher levels of catalase than nontransgenic litter-mates (29) . In mice of the V.5 line that were used in this study, untreated mice had a 3.9-fold increase in catalase activity when compared with non-transgenic littermates (Table I) . In response to feeding ciprofibrate for 3 weeks, catalase activity increased 3-fold in non-transgenic mice, and a modest increase in catalase activity was observed in transgenic mice. While transgenic mice still had 1.5-fold more catalase activity than non-transgenic mice after ciprofibrate feeding, this difference was not statistically significant. Activity of the H 2 O 2 -producing enzyme, FAO, was similar in transgenic and non-transgenic mice, which indicates that catalase overexpression did not alter this peroxisomal enzyme. Ciprofibrate induced FAO activity in both transgenic and non-transgenic mice, although FAO induction was somewhat less in transgenic mice. Although the levels of FAO and catalase were not significantly different between transgenic and non-transgenic mice after ciprofibrate treatment, the ratio of FAO to catalase activity was significantly different (Table I) .
Peroxisome proliferator-induced hepatomegaly in rodents is caused by both the increase in the size and number of peroxisomes as well as increased hepatocyte proliferation (8, 34) . In non-transgenic mice, ciprofibrate produced a 2-fold increase in liver wt and in the liver to body wt ratio (Table  II) . In transgenic animals, liver wt and the liver to body wt ratio were significantly increased in untreated mice, but not in ciprofibrate-treated mice, resulting in only a 1.5-fold increase after ciprofibrate feeding. Body wt was also significantly increased in transgenic mice. Therefore, we determined whether a decrease in cell proliferation contributed to this modest inhibition in liver wt gain. We used the BrdU immunohistochemical staining method (32) to quantify the rate of DNA synthesis. The basal rates of DNA synthesis were similar in untreated transgenic and non-transgenic mice (Figure 1 ). After ciprofibrate treatment, the rate of DNA synthesis increased 4-fold in non-transgenic mice, whereas the induction of DNA synthesis was only 2-fold in transgenic mice ( Figure 1) ; the difference between the treated transgenic and non-transgenic mice was statistically significant. This result showed that catalase overexpression was effective in partially blocking replicative DNA synthesis induced by ciprofibrate.
Reactive oxygen species such as H 2 O 2 are known to regulate the activity of several transcription factors, including NF-κB (20, 35) . We previously showed that NF-κB activity is increased in rats upon treatment with ciprofibrate (16) . In addition, NF-κB is modulated by changes in cell proliferation (23, 36) . Therefore, EMSAs were performed to determine whether NF-κB activity was influenced by catalase overexpression in control and ciprofibrate-treated mice. NF-κB levels were very low and similar to each other in untreated transgenic and nontransgenic mice (Figure 2 ). An increase in NF-κB DNA binding activity was observed in non-transgenic mice that were treated for 21 days with ciprofibrate, which supports our previous data in rats (16) . Densitometric analysis indicated that this represented nearly a 10-fold increase in NF-κB binding activity ( Figure 2B ). Ciprofibrate-mediated NF-κB activation was diminished in catalase transgenic mice, which supports the notion that H 2 O 2 contributes to NF-κB activation (Figure 2, panels A and B) . To confirm that the ciprofibrateinduced complex shown in Figure 2 was indeed NF-κB, we performed cold-competition and supershift assays using extracts from ciprofibrate-treated non-transgenic mice ( Figure Fig. 6 . Sp1 DNA binding activity is not affected by ciprofibrate treatment or catalase overexpression. EMSAs were performed using a radiolabeled probe containing an Sp1 binding site with no extract (lane 1), or 10 µg of extract from a single mouse. Extracts from non-transgenic control mice (lanes 2 and 3), transgenic control mice (lanes 4 and 5), non-transgenic, ciprofibrate-treated mice (lanes 6 and 7) or transgenic, ciprofibrate-treated mice (lanes 8 and 9). F.P., free probe.
3). When a 50-fold molar excess of an unlabeled, size matched heterologous (Sp1) oligonucleotide was included, no decrease in the binding of the radioactive band was seen (lane 3). Inclusion of a 25-fold or a 50-fold molar excess of unlabeled NF-κB oligonucleotide effectively competed for binding of the radioactive NF-κB probe (lanes 4 and 5). The addition of anti-p50 antibodies produced a supershift complex, which indicated that this subunit was present in the complex (lane 6). Including anti-p65 antibodies did not produce a supershifted band but rather reduced the intensity of the complex (lane 7). These results are consistent with previous studies using these antibodies; anti-p50 antibodies bind to the NF-κB/DNA complex resulting in a supershifted band, while the anti-p65 antibodies bind to and disrupt the NF-κB-DNA complex (16, 37) .
The activity of the transcription factor AP-1 is increased during cell proliferation and can be increased by reactive oxygen species (25) (26) (27) (28) , which suggests that AP-1 activity could also be influenced by altered catalase expression. Therefore we used EMSAs to measure AP-1 activity in the different groups of mice. In untreated mice, AP-1 levels were similar in control and transgenic mice (Figure 4) . After ciprofibrate treatment, AP-1 activity increased 4-fold in non-transgenic mice, and catalase overexpression decreased AP-1 activity 40% in ciprofibrate-treated mice. While this result suggests that catalase overexpression might reduce AP-1 induction, the difference was not statistically significant. Controls from ciprofibrate treated non-transgenic mouse nuclear extracts confirmed that the induced band was indeed AP-1 ( Figure 5 ). The addition of a 50-fold molar excess of an unlabeled heterologous fragment did not decrease the intensity of the band (compare lane 3 with lane 2), whereas adding either a 25-or 50-fold molar excess of the unlabeled AP-1 oligonucleotide effectively competed for binding to the radiolabeled AP-1 probes (lanes 4 and 5) . The addition of anti-c-fos and anti-cjun antibodies completely eliminated the complex (lane 6), providing additional evidence that the radioactive band contained AP-1.
Sp1 is a relatively ubiquitous transcription factor that is involved in the regulation of numerous genes (38) . Sp1 activity is down-regulated upon terminal differentiation in the liver, but is increased by regenerating adult liver by dephosphorylation of the Sp1 protein (39) . We tested whether Sp1 DNA binding activity was affected by ciprofibrate treatment, and if so, whether this would be influenced by increased catalase activity. EMSAs with a radiolabeled Sp1 probe indicated that Sp1 activity remained unchanged upon ciprofibrate treatment, regardless of catalase overexpression ( Figure 6 ).
Discussion
The mechanism by which peroxisome proliferators promote hepatocellular carcinomas in rodents is not fully understood. Since these compounds induce cell proliferation, this may increase the likelihood of progression towards uncontrolled cell growth. Because peroxisome proliferators increase the activity of H 2 O 2 -generating enzymes, it is also possible that oxidative stress can lead to cellular transformation. The link between cellular transformation and oxidative stress is supported by two studies which show that overexpression of the H 2 O 2 -generating enzymes FAO or urate oxidase leads to the transformation of cultured mammalian cells (40, 41) . Using transgenic mice to overexpress the peroxisomal H 2 O 2 -catabolizing enzyme catalase, we have further explored the role of H 2 O 2 with regards to peroxisome proliferator-induced cellular changes.
In untreated animals, the levels of catalase were nearly 4-fold higher in transgenic mice than in non-transgenic littermates, while the levels of FAO were very similar. Both groups of animals were capable of responding to ciprofibrate, as measured by increased FAO levels after treatment. After ciprofibrate treatment, catalase levels were only 1.5-fold higher in transgenic mice than in non-transgenic mice. While the difference in catalase levels was not significant in these two groups of mice after ciprofibrate treatment, we did observe that the ratio of FAO activity to catalase activity was nearly 2-fold higher in non-transgenic mice than in transgenic mice, a difference that was statistically significant. Since the ratio of these two enzymes may reflect the amount of H 2 O 2 released from peroxisomes, it is likely that the levels of reactive oxygen species were lower in transgenic mice than in non-transgenic mice after ciprofibrate treatment.
Our results showed that catalase overexpression inhibits ciprofibrate-induced replicative DNA synthesis. Even though this block was not complete, it did represent an 60% inhibition of DNA synthesis. This implies that H 2 O 2 may be necessary for increasing DNA synthesis through a yet unknown mechanism. It is possible that H 2 O 2 is involved in signal transduction pathways leading to progression into the cell cycle. It was recently postulated that H 2 O 2 plays a role as a signal transducer in vascular smooth muscle cells (42) . Overall, these data demonstrate an association between H 2 O 2 production and DNA synthesis, and indicate that inhibiting cell proliferation is at least partially responsible for the reduction in liver wt gain in catalase transgenic mice after feeding ciprofibrate.
Our results suggest that ciprofibrate-mediated NF-κB activation is mediated by H 2 O 2 , because catalase overexpression could block this activation. Catalase overexpression, however, did not significantly inhibit the DNA binding activity of AP-1 in ciprofibrate-fed mice (although it was~40% lower). Since AP-1 also can be activated by active oxygen (20, 27, 28) , it is therefore possible that other factors may be important in the activation of both NF-κB and AP-1 in ciprofibrate-treated animals. The activation of both AP-1 and NF-κB has been shown to be regulated by other factors (19, 43) . Finally, it is possible that changes in the DNA binding activity of these transcription factors does not necessarily reflect changes in transcriptional activity (43) .
Although H 2 O 2 is a strong inducer of NF-κB, the mechanism by which peroxisome proliferators activate this factor is not known. NF-κB is regulated by the release of the inhibitory protein IκB, and it is therefore possible that H 2 O 2 activates protein kinases, which are in turn responsible for the phosphorylation and subsequent release of IκB from NF-κB. Since NF-κB may be involved in cell proliferation (23) , activation of this factor may at least partially explain the difference in ciprofibrate-induced DNA synthesis in transgenic and nontransgenic mice. This possibility could be directly tested by specifically blocking the NF-κB activation in transgenic mice. Our results also suggest that the transcription of NF-κB regulated genes could be affected by peroxisome proliferators. We are currently attempting to identify these target genes in order to understand better the role of NF-κB in response to peroxisome proliferators.
In summary, our results indicate that catalase overexpression inhibits the ciprofibrate-mediated induction of DNA synthesis and NF-κB activation. The results in this study support the hypothesis that H 2 O 2 contributes towards the biochemical changes that are seen in response to peroxisome proliferators. These results, in combination with those of Chu et al. (40) , provide a possible mechanistic link between peroxisome proliferator administration, oxidative stress and cellular transformation. Whether or not catalase overexpression could block the tumorigenic properties of peroxisome proliferators will require further studies. These catalase transgenic mice may also be useful in evaluating the role of H 2 O 2 in other aspects of liver toxicity. For example, we have also shown that phenobarbital can activate liver NF-κB binding activity (37) . The ability of phenobarbital to activate potential reactive oxygen species-generating cytochrome P-450 enzymes, suggests that catalase overexpression could also influence biochemical changes in response to this, and perhaps other, liver tumor-promoting agents.
